Cargando…
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Over the past years, an increasing amount of evidence has emerged in support of the kynurenine pathway’s (KP) pivotal role in the pathogenesis of several neurodegenerative, psychiatric, vascular and autoimmune diseases. Different neuroactive metabolites of the KP are known to exert opposite effects...
Autores principales: | Biernacki, Tamás, Sandi, Dániel, Bencsik, Krisztina, Vécsei, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349747/ https://www.ncbi.nlm.nih.gov/pubmed/32604956 http://dx.doi.org/10.3390/cells9061564 |
Ejemplares similares
-
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
por: Sandi, Dániel, et al.
Publicado: (2022) -
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
por: Sandi, Dániel, et al.
Publicado: (2021) -
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
por: Biernacki, Tamás, et al.
Publicado: (2022) -
Contributing factors to health‐related quality of life in multiple sclerosis
por: Biernacki, Tamás, et al.
Publicado: (2019) -
Epidemiology of multiple sclerosis in Central Europe, update from Hungary
por: Biernacki, Tamás, et al.
Publicado: (2020)